WuXi AppTec is a trusted partner and contributor to the pharmaceutical and life sciences industries, providing R&D and manufacturing services that help advance healthcare innovation. With operations across Asia, Europe, and North America, we offer integrated, end-to-end services through our unique CRDMO (Contract Research, Development, and Manufacturing Organization) platform. We are privileged to work alongside partners across 30+ countries, supporting their efforts to bring breakthrough treatments to patients. Guided by our vision that every drug can be made and every disease can be treated, we are committed to advancing breakthroughs for patients—one collaboration at a time.
Supporting our customers to deliver groundbreaking treatments to patients around the world
Collaborating with partners to deliver comprehensive capabilities and innovative technologies in the pharmaceutical and healthcare industry
WuXi AppTec Receives Double “A” Rating from CDP for Climate Change and Water Security Leadership
WuXi AppTec Receives Frost & Sullivan’s 2025 Global Company of the Year Award in the CRDMO Industry
WuXi AppTec Looks to Extend CRDMO Platform to Saudi Arabia as It Signs Strategic MoUs with NEOM and Ministry of Health
WuXi AppTec Achieves Strong Double-Digit Growth in Revenue and Profit for Q1-Q3 2025; Backlog for Continuing Operations Up 41.2% YoY; Further Raises 2025 Full-year Guidance
WuXi AppTec Awarded Gold Medal by EcoVadis Sustainability Rating for Second Consecutive Year